Breckenridge unveils new generics
Breckenridge Pharmaceutical Inc. has received Food and Drug Administration approval for letrozole 2.5 mg tablets and estradiol/norethindrone acetate 0.5mg/0.1mg tablets.
Breckenridge Pharmaceutical Inc. has received Food and Drug Administration approval for letrozole 2.5 mg tablets and estradiol/norethindrone acetate 0.5mg/0.1mg tablets.
Forest Laboratories Inc. plans to roll out Daliresp tablets, a medication for chronic obstructive pulmonary disease (COPD), to U.S. pharmacies by mid-June.
Tropicana Products Inc. has added lemonade and raspberry lemonade flavors to its Trop50 fruit juice line, which has 50% less sugar and calories plus no artificial sweeteners.
Watson Pharmaceuticals Inc. is set to ship levonorgestrel and ethinyl estradiol birth control tablets. The company said this week that its subsidiary, Watson Laboratories Inc., received approval from the Food and Drug Administration for levonorgestrel and ethinyl estradiol tablets 0.09 mg/0.02 mg.
Upsher-Smith Laboratories Inc. has been recognized with a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) by the Healthcare Distribution Management Association (HDMA).
Vichy Laboratoires has introduced Capital Soleil, a new range of oil-free, allergy-tested sun care products designed to provide cellular protection from UVA/UVB rays and free radicals.
Pfizer Inc. is conducting what it said is the first-ever randomized clinical trial under an investigational new drug (IND) application that manages study participation entirely using electronic tools and enables patients to participate in the trial regardless of geography.
TheraBiogen Inc. has entered a national distribution agreement with Food Lion for its TheraMax homeopathic nasal sprays for the relief of cold, flu and allergy symptoms.
Medications for gout and gastroesophageal reflux disease (GERD) from Takeda Canada Inc. are now being covered by the Quebec provincial health plan. Takeda Canada, a division of Japan-based Takeda Pharmaceutical Co.
Boots has rolled out its No7 Protect & Perfect Intense Body Serum anti-aging body formula exclusively to Shoppers Drug Mart stores in Canada.
Procter & Gamble Co. has announced the several organizational changes in its global beauty care and grooming businesses. P&G said Tuesday that Charles (Chip) Bergh is retiring from the company after 28 years "to pursue his aspiration to be CEO of a major company.
Dr. Reddy’s Laboratories has released generic versions of medications for treating Alzheimer’s disease, depression and breast cancer in the United States.
Mitchell Bowlus, chief financial officer at ECRM, has been appointed president at retail and consumer product manufacturer solution provider.
Carex Health Brands has opened its new corporate headquarters in the Boston area. The home health care manufacturer said Wednesday that the new East Coast headquarters, in Norwell, Mass.
Teva Pharmaceutical Industries Ltd. has rolled out donepezil hydrochloride tablets, a medication for Alzheimer’s disease. The company said Wednesday that it has received Food and Drug Administration approval to market a generic version of Eisai’s Aricept Tablets in strengths of 5 mg and 10 mg.
TheraBiogen Inc. has introduced its third product, TheraMax Migraine Relief homeopathic nasal spray. The company said Wednesday that TheraMax Migraine Relief is slated to ship to retailers before the end of the year.